• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻腔给药吸收面临的挑战:我们取得了多大进展?

Challenges in nasal drug absorption: how far have we come?

作者信息

Agu Remigius U

机构信息

Biopharmaceutics & Drug Delivery Lab, College of Pharmacy, 5968 College Street, PO Box 15000, Halifax, NS B3H 4R2, Canada.

出版信息

Ther Deliv. 2016 Jul;7(7):495-510. doi: 10.4155/tde-2016-0022.

DOI:10.4155/tde-2016-0022
PMID:27403632
Abstract

The nasal route is commonly used for local delivery of drugs to treat inflammatory conditions. It is also an attractive route for systemic delivery of some drugs. Irrespective of intended use, administered drugs must permeate the epithelial or olfactory membrane to be effective. The enthusiasm for potential use of the nasal route for systemic drug delivery has not been met by comparable success. In this paper, the anatomical and physiological attributes of the nasal cavity and paranasal sinuses important for drug delivery and challenges limiting drug absorption are discussed. Efforts made so far in improving nasal drug absorption such as overcoming restrictive nasal geometry and paranasal sinuses accessibility, mucociliary clearance, absorption barriers, metabolism and drug physicochemical challenges are discussed. Highlights on future prospects of nasal drug delivery/absorption were discussed.

摘要

鼻腔途径通常用于局部给药以治疗炎症性疾病。它也是一些药物全身给药的理想途径。无论预期用途如何,给药药物都必须穿透上皮或嗅膜才能发挥作用。鼻腔途径用于全身药物递送的潜在用途的热情尚未取得相应的成功。本文讨论了鼻腔和鼻窦对药物递送重要的解剖学和生理学特性以及限制药物吸收的挑战。还讨论了迄今为止在改善鼻腔药物吸收方面所做的努力,例如克服鼻腔几何形状和鼻窦可及性的限制、黏液纤毛清除、吸收屏障、代谢和药物物理化学方面的挑战。文中还讨论了鼻腔药物递送/吸收的未来前景要点。

相似文献

1
Challenges in nasal drug absorption: how far have we come?鼻腔给药吸收面临的挑战:我们取得了多大进展?
Ther Deliv. 2016 Jul;7(7):495-510. doi: 10.4155/tde-2016-0022.
2
Nasal clearance in health and disease.健康与疾病状态下的鼻腔清除功能。
J Aerosol Med. 2006 Spring;19(1):92-9. doi: 10.1089/jam.2006.19.92.
3
Mucoadhesive in situ nasal gelling drug delivery systems for modulated drug delivery.用于调节药物递送的黏膜黏附性原位鼻腔凝胶给药系统。
Expert Opin Drug Deliv. 2013 Jan;10(1):115-30. doi: 10.1517/17425247.2013.746659. Epub 2012 Nov 30.
4
Nasal route and drug delivery systems.鼻内给药途径与给药系统。
Pharm World Sci. 2004 Jun;26(3):137-42. doi: 10.1023/b:phar.0000026823.82950.ff.
5
Nasal delivery of high molecular weight drugs.高分子量药物的鼻腔给药。
Molecules. 2009 Sep 23;14(9):3754-79. doi: 10.3390/molecules14093754.
6
Potential of nanoparticulate drug delivery systems by intranasal administration.经鼻腔给药的纳米颗粒药物传递系统的潜力。
Curr Pharm Des. 2010 May;16(14):1644-53. doi: 10.2174/138161210791164108.
7
The nasal mucociliary clearance: relevance to nasal drug delivery.鼻黏膜纤毛清除:与鼻腔给药的相关性。
Pharm Res. 1991 Jul;8(7):807-14. doi: 10.1023/a:1015830907632.
8
Drug delivery to paranasal sinuses using pulsating aerosols.经鼻腔脉冲气溶胶给药。
J Aerosol Med Pulm Drug Deliv. 2014 Aug;27(4):255-63. doi: 10.1089/jamp.2013.1071.
9
Physicochemical and physiological considerations for efficient nose-to-brain targeting.用于提高脑靶向效率的物理化学和生理学考虑因素。
Expert Opin Drug Deliv. 2012 Jan;9(1):19-31. doi: 10.1517/17425247.2012.636801. Epub 2011 Dec 16.
10
Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules.全身作用药物的鼻内给药:小分子和生物大分子
Eur J Pharm Biopharm. 2014 Sep;88(1):8-27. doi: 10.1016/j.ejpb.2014.03.004. Epub 2014 Mar 28.

引用本文的文献

1
From Better Diagnostics to Earlier Treatment: The Rapidly Evolving Alzheimer's Disease Landscape.从更好的诊断到更早的治疗:快速演变的阿尔茨海默病格局
Medicina (Kaunas). 2025 Aug 14;61(8):1462. doi: 10.3390/medicina61081462.
2
Gellan Gum-Based In Situ Hydrogels for Nasal Delivery of Polymeric Micelles Loaded with Risperidone.基于结冷胶的原位水凝胶用于载有利培酮的聚合物胶束的鼻腔给药
Gels. 2025 May 28;11(6):404. doi: 10.3390/gels11060404.
3
Advancements in nose-to-brain drug targeting for Alzheimer's disease: a review of nanocarriers and clinical insights.
用于阿尔茨海默病的鼻脑靶向给药进展:纳米载体综述与临床见解
Inflammopharmacology. 2025 Feb;33(2):605-626. doi: 10.1007/s10787-024-01636-3. Epub 2025 Jan 7.
4
Serum Albumin in Nasal Drug Delivery Systems: Exploring the Role and Application.鼻腔给药系统中的血清白蛋白:探索其作用与应用
Pharmaceutics. 2024 Oct 11;16(10):1322. doi: 10.3390/pharmaceutics16101322.
5
Intranasal Drug Administration in Alzheimer-Type Dementia: Towards Clinical Applications.阿尔茨海默病型痴呆的鼻内给药:迈向临床应用
Pharmaceutics. 2023 May 3;15(5):1399. doi: 10.3390/pharmaceutics15051399.
6
Design and Development of Levodopa Loaded Polymeric Nanoparticles for Intranasal Delivery.用于鼻内给药的左旋多巴负载型聚合物纳米颗粒的设计与开发
Pharmaceuticals (Basel). 2022 Mar 18;15(3):370. doi: 10.3390/ph15030370.
7
First-line management of canine status epilepticus at home and in hospital-opportunities and limitations of the various administration routes of benzodiazepines.犬癫痫持续状态在家中和医院的一线管理——苯二氮䓬类药物各种给药途径的机遇与局限
BMC Vet Res. 2021 Mar 4;17(1):103. doi: 10.1186/s12917-021-02805-0.